Alternative lengthening of telomeres: Recurrent cytogenetic aberrations and chromosome stability under extreme telomere dysfunction

Neoplasia (United States)

Volumn 15, Issue 11, 2013, Pages 1301-1313

  Sakellariou, Despoina ^a   Chiourea, Maria ^a   Raftopoulou, Christina ^a   Gagos, Sarantis ^a  

^a BIOMEDICAL RESEARCH FOUNDATION   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

TELOMERASE; TELOMERASE REVERSE TRANSCRIPTASE;

ARTICLE; CHROMOSOMAL INSTABILITY; CHROMOSOME ABERRATION; CHROMOSOME FRAGILE SITE; CHROMOSOME REARRANGEMENT; CYTOGENETICS; ENZYME ACTIVITY; EPIGENETICS; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; KARYOTYPE; NEOPLASM; OSTEOSARCOMA CELL; POLYPLOIDY; PRIORITY JOURNAL; TELOMERE HOMEOSTASIS;

CELL LINE, TUMOR; CHROMOSOMAL INSTABILITY; CHROMOSOME ABERRATIONS; CHROMOSOMES, HUMAN; HUMANS; KARYOTYPING; TELOMERE; TELOMERE HOMEOSTASIS; TRANSLOCATION, GENETIC;

EID: 84888411928     PISSN: 15228002     EISSN: 14765586     Source Type: Journal    
DOI: 10.1593/neo.131574     Document Type: Article

References (117)

1. Halazonetis TD, Gorgoulis VG, and Bartek J (2008). An oncogene-induced DNA damage model for cancer development. Science 319, 1352-1355.
2. Kazda A, Zellinger B, Rössler M, Derboven E, Kusenda B, and Riha K (2012). Chromosome end protection by blunt-ended telomeres. Genes Dev 26, 1703-1713.
3. Gagos S and Irminger-Finger I (2005). Chromosome instability in neoplasia: chaotic roots to continuous growth. Int J Biochem Cell Biol 37, 1014-1033.
4. Roschke AV and Kirsch IR (2010). Targeting karyotypic complexity and chromosomal instability of cancer cells. Curr Drug Targets 11, 1341-1350.
5. Eckert CA, Gravdahl DJ, and Megee PC (2007). The enhancement of pericentromeric cohesin association by conserved kinetochore components promotes highfidelity chromosome segregation and is sensitive to microtubule-based tension. Genes Dev 21, 278-291.
6. Silva P, Barbosa J, Nascimento AV, Faria J, Reis R, and Bousbaa H (2011). Monitoring the fidelity of mitotic chromosome segregation by the spindle assembly checkpoint. Cell Prolif 44, 391-400.
7. Greaves M and Maley CC (2012). Clonal evolution in cancer. Nature 481, 306-313.
8. Stratton MR (2011). Exploring the genomes of cancer cells: progress and promise. Science 331, 1553-1558.
9. Durkin SG and Glover TW (2007). Chromosome fragile sites. Annu Rev Genet 41, 169-192.
10. Dillon LW, Burrow AA, and Wang YH (2010). DNA instability at chromosomal fragile sites in cancer. Curr Genomics 11, 326-337.
11. Sideridou M, Zakopoulou R, Evangelou K, Liontos M, Kotsinas A, Rampakakis E, Gagos S, Kahata K, Grabusic K, Gkouskou K, et al. (2011). Cdc6 expression represses E-cadherin transcription and activates adjacent replication origins. J Cell Biol 195, 1123-1140.
12. Debatisse M, Le Tallec B, Letessier A, Dutrillaux B, and Brison O (2012). Common fragile sites: mechanisms of instability revisited. Trends Genet 28, 22-32.
13. Ma K, Qiu L, Mrasek K, Zhang J, Liehr T, Quintana LG, and Li Z (2012). Common fragile sites: genomic hotspots of DNA damage and carcinogenesis. Int J Mol Sci 13, 11974-11999.
14. Blasco MA (2005). Telomeres and human disease: ageing, cancer and beyond. Nat Rev Genet 6, 611-622.
15. Bryan TM, Englezou A, Gupta J, Bacchetti S, and Reddel RR (1995). Telomere elongation in immortal human cells without detectable telomerase activity. EMBO J 14, 4240-4248.
16. Sabatier L, Ricoul M, Pottier G, and Murnane JP (2005). The loss of a single telomere can result in instability of multiple chromosomes in a human tumor cell line. Mol Cancer Res 3, 139-150.
17. Kim NW, Piatyszek MA, Prowse KR, Harley CB, West MD, Ho PL, Coviello GM, Wright WE, Weinrich SL, and Shay JW (1994). Specific association of human telomerase activity with immortal cells and cancer. Science 266, 2011-2015.
18. Rizki A and Lundblad V (2001). Defects in mismatch repair promote telomeraseindependent proliferation. Nature 411, 713-716.
19. Henson JD and Reddel RR (2010). Assaying and investigating Alternative Lengthening of Telomeres activity in human cells and cancers. FEBS Lett 584, 3800-3811.
20. Shay JW, Reddel RR, and Wright WE (2012). Cancer and telomeres-an ALTernative to telomerase. Science 336, 1388-1390.
21. Daniel A, St Heaps L, Sylvester D, Diaz S, and Peters G (2008). Two mosaic terminal inverted duplications arising post-zygotically: Evidence for possible formation of neo-telomeres. Cell Chromosome 7, 1.
22. Cesare AJ and Reddel RR (2010). Alternative lengthening of telomeres: models, mechanisms and implications. Nat Rev Genet 11, 319-330.
23. Nabetani A and Ishikawa F (2011). Alternative lengthening of telomeres pathway: recombination-mediated telomere maintenance mechanism in human cells. J Biochem 149, 5-14.
24. Gagos S, Chiourea M, Christodoulidou A, Apostolou E, Raftopoulou C, Deustch S, Jefford CE, Irminger-Finger I, Shay JW, and Antonarakis SE (2008). Pericentromeric instability and spontaneous emergence of human neoacrocentric and minute chromosomes in the alternative pathway of telomere lengthening. Cancer Res 68, 8146-8155.
25. Gisselsson D (2005). Mitotic instability in cancer: is there method in the madness? Cell Cycle 4, 1007-1010.
26. Gorringe KL, Chin SF, Pharoah P, Staines JM, Oliveira C, Edwards PA, and Caldas C (2005). Evidence that both genetic instability and selection contribute to the accumulation of chromosome alterations in cancer. Carcinogenesis 26, 923-930.
27. Meeker AK, Hicks JL, Iacobuzio-Donahue CA, Montgomery EA, Westra WH, Chan TY, Ronnett BM, and De Marzo AM (2004). Telomere length abnormalities occur early in the initiation of epithelial carcinogenesis. Clin Cancer Res 10, 3317-3326.
28. Mitelman F, Johansson B, and Mertens F (2007). The impact of translocations and gene fusions on cancer causation. Nat Rev Cancer 7, 233-245.
29. Lovejoy CA, Li W, Reisenweber S, Thongthip S, Bruno J, de Lange T, De S, Petrini JH, Sung PA, Jasin M, et al. (2012). Loss of ATRX, genome instability, and an altered DNA damage response are hallmarks of the alternative lengthening of telomeres pathway. PLoS Genet 8, e1002772.
30. Dessain SK, Yu H, Reddel RR, Beijersbergen RL, and Weinberg RA (2000). Methylation of the human telomerase gene CpG island. Cancer Res 60, 537-541.
31. Ford LP, Zou Y, Pongracz K, Gryaznov SM, Shay JW, and Wright WE (2001). Telomerase can inhibit the recombination-based pathway of telomere maintenance in human cells. J Biol Chem 276, 32198-32203.
32. Capo-Chichi CD, Smith ER, Yang DH, Roland IH, Vanderveer L, Cohen C, Hamilton TC, Godwin AK, and Xu XX (2002). Dynamic alterations of the extracellular environment of ovarian surface epithelial cells in premalignant transformation, tumorigenicity, and metastasis. Cancer 95, 1802-1815.
33. ISCN (2009). An International System for Human Cytogenetic Nomenclature. S. Karger, Basel, Switzerland.
34. Campbell LJ (2011). Cytogenetic analysis and reporting. Methods Mol Biol 730, 259-268.
35. Bailey SM, Cornforth MN, Kurimasa A, Chen DJ, and Goodwin EH (2001). Strand-specific postreplicative processing of mammalian telomeres. Science 293, 2462-2465.
36. Fabarius A, Hehlmann R, and Duesberg PH (2003). Instability of chromosome structure in cancer cells increases exponentially with degrees of aneuploidy. Cancer Genet Cytogenet 143, 59-72.
37. Li R, Hehlman R, Sachs R, and Duesberg P (2005). Chromosomal alterations cause the high rates and wide ranges of drug resistance in cancer cells. Cancer Genet Cytogenet 163, 44-56.
38. Christodoulidou A, Raftopoulou C, Chiourea M, Papaioannou GK, Hoshiyama H, Wright WE, Shay JW, and Gagos S (2013). The roles of telomerase in the generation of polyploidy during neoplastic cell growth. Neoplasia 15, 156-168.
39. Cancer Genomics Program. SKY Karyotypes and FISH Analysis of Epithelial Cancer Cell Lines Database. Available at: http://www.path.cam.ac.uk/~pawefish/index.html.
40. Kawai K, Viars C, Arden K, Tarin D, Urquidi V, and Goodison S (2002). Comprehensive karyotyping of the HT-29 colon adenocarcinoma cell line. Genes Chromosomes Cancer 34, 1-8.
41. Makridakis M, Gagos S, Petrolekas A, Roubelakis MG, Bitsika V, Stravodimos K, Pavlakis K, Anagnou NP, Coleman J, and Vlahou A (2009). Chromosomal and proteome analysis of a new T24-based cell line model for aggressive bladder cancer. Proteomics 9, 287-298.
42. Macville M, Schröck E, Padilla-Nash H, Keck C, Ghadimi BM, Zimonjic D, Popescu N, and Ried T (1999). Comprehensive and definitivemolecular cytogenetic characterization of HeLa cells by spectral karyotyping. Cancer Res 59, 141-150.
43. Vitre BD and Cleveland DW (2012). Centrosomes, chromosome instability (CIN) and aneuploidy. Curr Opin Cell Biol 24, 809-815.
44. Desmaze C, Soria JC, Freulet-Marriere MA, Mathieu N, and Sabatier L (2003). Telomere-driven genomic instability in cancer cells. Cancer Lett 194, 173-182.
45. Azzalin CM, Nergadze SG, and Giulotto E (2001). Human intrachromosomal telomeric-like repeats: sequence organization and mechanisms of origin. Chromosoma 110, 75-82.
46. Stimpson KM, Matheny JE, and Sullivan BA (2012). Dicentric chromosomes: unique models to study centromere function and inactivation. Chromosome Res 20, 595-605.
47. Black BE and Cleveland DW (2011). Epigenetic centromere propagation and the nature of CENP-a nucleosomes. Cell 144, 471-479.
48. Sfeir A, Kosiyatrakul ST, Hockemeyer D, MacRae SL, Karlseder J, Schildkraut CL, and de Lange T (2009). Mammalian telomeres resemble fragile sites and require TRF1 for efficient replication. Cell 138, 90-103.
49. Gerlinger M, Rowan AJ, Horswell S, Larkin J, Endesfelder D, Gronroos E, Martinez P, Matthews N, Stewart A, Tarpey P, et al. (2012). Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. N Engl J Med 366, 883-892.
50. Podlaha O, Riester M, De S, and Michor F (2012). Evolution of the cancer genome. Trends Genet 28, 155-163.
51. Scheel C, Schaefer KL, Jauch A, Keller M, Wai D, Brinkschmidt C, van Valen F, Boecker W, Dockhorn-Dworniczak B, and Poremba C (2001). Alternative lengthening of telomeres is associated with chromosomal instability in osteosarcomas. Oncogene 20, 3835-3844.
52. Davoli T, Denchi EL, and de Lange T (2010). Persistent telomere damage induces bypass of mitosis and tetraploidy. Cell 141, 81-93.
53. Gisselsson D, Pettersson L, Höglund M, Heidenblad M, Gorunova L, Wiegant J, Mertens F, Dal Cin P, Mitelman F, and Mandahl N (2000). Chromosomal breakage-fusion-bridge events cause genetic intratumor heterogeneity. Proc Natl Acad Sci USA 97, 5357-5362.
54. Martínez AC and van Wely KH (2010). Are aneuploidy and chromosome breakage caused by a CINgle mechanism? Cell Cycle 9, 2275-2280.
55. Erenpreisa J and Cragg MS (2010). MOS, aneuploidy and the ploidy cycle of cancer cells. Oncogene 29, 5447-5451.
56. Zalzman M, Falco G, Sharova LV, Nishiyama A, Thomas M, Lee SL, Stagg CA, Hoang HG, Yang HT, Indig FE, et al. (2010). Zscan4 regulates telomere elongation and genomic stability in ES cells. Nature 464, 858-863.
57. Wang F, Yin Y, Ye X, Liu K, Zhu H, Wang L, Chiourea M, Okuka M, Ji G, Dan J, et al. (2012). Molecular insights into the heterogeneity of telomere reprogramming in induced pluripotent stem cells. Cell Res 22, 757-768.
58. Jaco I, Canela A, Vera E, and Blasco MA (2008). Centromere mitotic recombination in mammalian cells. J Cell Biol 181, 885-892.
59. Klinakis A, Lobry C, Abdel-Wahab O, Oh P, Haeno H, Buonamici S, van De Walle I, Cathelin S, Trimarchi T, Araldi E, et al. (2011). A novel tumoursuppressor function for the Notch pathway in myeloid leukaemia. Nature 473, 230-233.
60. Gonzalvez F, Lawrence D, Yang B, Yee S, Pitti R, Marsters S, Pham VC, Stephan JP, Lill J, and Ashkenazi A (2012). TRAF2 sets a threshold for extrinsic apoptosis by tagging caspase-8 with a ubiquitin shutoff timer. Mol Cell 48, 888-899.
61. Aiyar SE, Cho H, Lee J, and Li R (2007). Concerted transcriptional regulation by BRCA1 and COBRA1 in breast cancer cells. Int J Biol Sci 3, 486-492.
62. Chabchoub E, Rodriguez L, Galán E, Mansilla E, Martínez-Fernandez ML, Martínez-Frías ML, Fryns JP, and Vermeesch JR (2007). Molecular characterisation of a mosaicism with a complex chromosome rearrangement: evidence for coincident chromosome healing by telomere capture and neo-telomere formation. J Med Genet 44, 250-256.
63. Gonzalo S, Jaco I, Fraga MF, Chen T, Li E, Esteller M, and Blasco MA (2006). DNA methyltransferases control telomere length and telomere recombination in mammalian cells. Nat Cell Biol 8, 416-424.
64. Ji G, Liu K, Chen C, Ruan W, Glytsou C, Yang Y, Okuka M, Song W, Gagos S, Li N, et al. (2012). Conservation and characterization of unique porcine interstitial telomeric sequences. Sci China Life Sci 55, 1029-1037.
65. Solovjeva LV, Demin SJ, Pleskach NM, Kuznetsova MO, and Svetlova MP (2012). Characterization of telomeric repeats in metaphase chromosomes and interphase nuclei of Syrian Hamster Fibroblasts. Mol Cytogenet 5, 37.
66. Lee C, Sasi R, and Lin CC (1993). Interstitial localization of telomeric DNA sequences in the Indian muntjac chromosomes: further evidence for tandem chromosome fusions in the karyotypic evolution of the Asian muntjacs. Cytogenet Cell Genet 63, 156-159.
67. Tsantoulis PK, Kotsinas A, Sfikakis PP, Evangelou K, Sideridou M, Levy B, Mo L, Kittas C, Wu XR, Papavassiliou AG, et al. (2008). Oncogene-induced replication stress preferentially targets common fragile sites in preneoplastic lesions. A genome-wide study. Oncogene 27, 3256-3264.
68. GeneCards: The Human Gene Compendium. Available at: www.genecards.org.
69. Carroll CW, Silva MC, Godek KM, Jansen LE, and Straight AF (2009). Centromere assembly requires the direct recognition of CENP-A nucleosomes by CENP-N. Nat Cell Biol 11, 896-902.
70. Khuong-Quang DA, Buczkowicz P, Rakopoulos P, Liu XY, Fontebasso AM, Bouffet E, Bartels U, Albrecht S, Schwartzentruber J, Letourneau L, et al. (2012). K27M mutation in histone H3.3 defines clinically and biologically distinct subgroups of pediatric diffuse intrinsic pontine gliomas. Acta Neuropathol 124, 439-447.
71. Ritchie K, Seah C, Moulin J, Isaac C, Dick F, and Bérubé NG (2008). Loss of ATRX leads to chromosome cohesion and congression defects. J Cell Biol 180, 315-324.
72. Dong Z, Pang JS, Ng MH, Poon WS, Zhou L, and Ng HK (2004). Identification of two contiguous minimally deleted regions on chromosome 1p36.31- p36.32 in oligodendroglial tumours. Br J Cancer 91, 1105-1111.
73. Idbaih A, Marie Y, Pierron G, Brennetot C, Hoang-Xuan K, Kujas M, Mokhtari K, Sanson M, Lejeune J, Aurias A, et al. (2005). Two types of chromosome 1p losses with opposite significance in gliomas. Ann Neurol 58, 483-487.
74. Maringele L and Lydall D (2004). EXO1 plays a role in generating type I and type II survivors in budding yeast. Genetics 166, 1641-1649.
75. Massagué J, Seoane J, and Wotton D (2005). Smad transcription factors. Genes Dev 19, 2783-2810.
76. Gigek CO, Lisboa LC, Leal MF, Silva PN, Lima EM, Khayat AS, Assumpção PP, Burbano RR, and Smith Mde A (2011). SMARCA5 methylation and expression in gastric cancer. Cancer Invest 29, 162-166.
77. Shay JW and Wright WE (2000). Implications of mapping the human telomerase gene (hTERT) as the most distal gene on chromosome 5p. Neoplasia 2, 195-196.
78. Hoare SF, Bryce LA, Wisman GB, Burns S, Going JJ, van der Zee AG, and Keith WN (2001). Lack of telomerase RNA gene hTERC expression in alternative lengthening of telomeres cells is associated with methylation of the hTERC promoter. Cancer Res 61, 27-32.
79. Atkinson SP, Hoare SF, Glasspool RM, and Keith WN (2005). Lack of telomerase gene expression in alternative lengthening of telomere cells is associated with chromatin remodeling of the hTR and hTERT gene promoters. Cancer Res 65, 7585-7590.
80. Zhang Y, Cai L, Wei RX, Hu H, Jin W, and Zhu XB (2011). Different expression of alternative lengthening of telomere (ALT)-associated proteins/mRNAs in osteosarcoma cell lines. Oncol Lett 2, 1327-1332.
81. Heaphy CM, Subhawong AP, Hong SM, Goggins MG, Montgomery EA, Gabrielson E, Netto GJ, Epstein JI, Lotan TL, Westra WH, et al. (2011). Prevalence of the alternative lengthening of telomeres telomere maintenance mechanism in human cancer subtypes. Am J Pathol 179, 1608-1615.
82. Peuscher MH and Jacobs JJ (2011). DNA-damage response and repair activities at uncapped telomeres depend on RNF8. Nat Cell Biol 13, 1139-1145.
83. Zhang R, Chen W, and Adams PD (2007). Molecular dissection of formation of senescence-associated heterochromatin foci. Mol Cell Biol 27, 2343-2358.
84. Sebastian S, Sreenivas P, Sambasivan R, Cheedipudi S, Kandalla P, Pavlath GK, and Dhawan J (2009). MLL5, a trithorax homolog, indirectly regulates H3K4 methylation, represses cyclin A2 expression, and promotes myogenic differentiation. Proc Natl Acad Sci USA 106, 4719-4724.
85. Whelan G, Kreidl E, Wutz G, Egner A, Peters JM, and Eichele G (2012). Cohesin acetyltransferase Esco2 is a cell viability factor and is required for cohesion in pericentric heterochromatin. EMBO J 31, 71-82.
86. Yuan K, Li N, Jiang K, Zhu T, Huo Y, Wang C, Lu J, Shaw A, Thomas K, Zhang J, et al. (2009). PinX1 is a novel microtubule-binding protein essential for accurate chromosome segregation. J Biol Chem 284, 23072-23082.
87. Yonekawa T, Yang S, and Counter CM (2012). PinX1 localizes to telomeres and stabilizes TRF1 at mitosis. Mol Cell Biol 32, 1387-1395.
88. Ha GH, Kim HS, Go H, Lee H, Seimiya H, Chung DH, and Lee CW (2012). Tankyrase-1 function at telomeres and during mitosis is regulated by Polo-like kinase-1-mediated phosphorylation. Cell Death Differ 19, 321-332.
89. Sudarsanam P, Cao Y, Wu L, Laurent BC, and Winston F (1999). The nucleosome remodeling complex, Snf/Swi, is required for the maintenance of transcription in vivo and is partially redundant with the histone acetyltransferase, Gcn5. EMBO J 18, 3101-3106.
90. Krskova L, Augustinakova A, Drahokoupilova E, Sumerauer D, Mudry P, and Kodet R (2011). Rhabdomyosarcoma: molecular analysis of Igf2, MyoD1 and Myogenin expression. Neoplasma 58, 415-423.
91. Tsutsui T, Kumakura S, Yamamoto A, Kanai H, Tamura Y, Kato T, Anpo M, Tahara H, and Barrett JC (2002). Association of p16INK4a and pRb inactivation with immortalization of human cells. Carcinogenesis 23, 2111-2117.
92. Caslini C, Connelly JA, Serna A, Broccoli D, and Hess JL (2009). MLL associates with telomeres and regulates telomeric repeat-containing RNA transcription. Mol Cell Biol 29, 4519-4526.
93. De Piccoli G, Cortes-Ledesma F, Ira G, Torres-Rosell J, Uhle S, Farmer S, Hwang JY, Machin F, Ceschia A, McAleenan A, et al. (2006). Smc5-Smc6 mediate DNA double-strand-break repair by promoting sister-chromatid recombination. Nat Cell Biol 8, 1032-1034.
94. Rezvani G, Lui JC, Barnes KM, and Baron J (2012). A set of imprinted genes required for normal body growth also promotes growth of rhabdomyosarcoma cells. Pediatr Res 71, 32-38.
95. Martins AS, Olmos D, Missiaglia E, and Shipley J (2011). Targeting the insulinlike growth factor pathway in rhabdomyosarcomas: rationale and future perspectives. Sarcoma 2011, 209736.
96. Bekker-Jensen S, Danielsen Rendtlew J, Fugger K, Gromova I, Nerstedt A, Lukas C, Bartek J, Lukas J, and Mailand N (2010). HERC2 coordinates ubiquitin-dependent assembly of DNA repair factors on damaged chromosomes. Nat Cell Biol 12, 80-86; sup. pp. 1-12.
97. Henson JD, Neumann AA, Yeager TR, and Reddel RR (2002). Alternative lengthening of telomeres in mammalian cells. Oncogene 21, 598-610.
98. Rogan EM, Bryan TM, Hukku B, Maclean K, Chang AC, Moy EL, Englezou A, Warneford SG, Dalla-Pozza L, and Reddel RR (1995). Alterations in p53 and p16INK4 expression and telomere length during spontaneous immortalization of Li-Fraumeni syndrome fibroblasts. Mol Cell Biol 15, 4745-4753.
99. Couch FJ, Wang X, McGuffog L, Lee A, Olswold C, Kuchenbaecker KB, Soucy P, Fredericksen Z, Barrowdale D, Dennis J, et al. (2013). Genome-wide association study in BRCA1 mutation carriers identifies novel loci associated with breast and ovarian cancer risk. PLoS Genet 9, e1003212.
100. Ohhata T, Araki R, Fukumura R, Kuroiwa A, Matsuda Y, and Abe M (2001). Cloning, genomic structure and chromosomal localization of the gene encoding mouse DNA helicase RECQL5β. Gene 280, 59-66.
101. Marchiò C, Natrajan R, Shiu KK, Lambros MB, Rodriguez-Pinilla SM, Tan DS, Lord CJ, Hungermann D, Fenwick K, Tamber N, et al. (2008). The genomic profile of HER2-amplified breast cancers: the influence of ER status. J Pathol 216, 399-407.
102. Mao X, Lillington D, Child F, Russell-Jones R, Young B, and Whittaker S (2002). Comparative genomic hybridization analysis of primary cutaneous B-cell lymphomas: identification of common genomic alterations in disease pathogenesis. Genes Chromosomes Cancer 35, 144-155.
103. National Center for Biotechnology Information (NCBI), Gene Database. Available at: www.ncbi.nlm.nih.gov/gene.
104. Höglund M, Gorunova L, Jonson T, Dawiskiba S, Andrén-Sandberg A, Stenman G, and Johansson B (1998). Cytogenetic and FISH analyses of pancreatic carcinoma reveal breaks in 18q11 with consistent loss of 18q12-qter and frequent gain of 18p. Br J Cancer 77, 1893-1899.
105. Schoeftner S and Blasco MA (2009). A 'higher order' of telomere regulation: telomere heterochromatin and telomeric RNAs. EMBO J 28, 2323-2336.
106. Yehezkel S, Segev Y, Viegas-Péquignot E, Skorecki K, and Selig S (2008). Hypomethylation of subtelomeric regions in ICF syndrome is associated with abnormally short telomeres and enhanced transcription from telomeric regions. Hum Mol Genet 17, 2776-2789.
107. Sillars-Hardebol AH, Carvalho B, Tijssen M, Belien JA, de Wit M, Delis-van Diemen PM, Pontén F, van de Wiel MA, Fijneman RJ, and Meijer GA (2012). TPX2 and AURKA promote 20q amplicon-driven colorectal adenoma to carcinoma progression. Gut 61, 1568-1575.
108. Smith DH, Christensen IJ, Jensen NF, Markussen B, Romer MU, Nygard SB, Muller S, Nielsen HJ, Brunner N, and Nielsen KV (2013). Mechanisms of topoisomerase I (TOP1) gene copy number increase in a stage III colorectal cancer patient cohort. PLoS One 8, e60613.
109. Delaval B and Doxsey SJ (2010). Pericentrin in cellular function and disease. J Cell Biol 188, 181-190.
110. Miller CW, Ikezoe T, Krug U, Hofmann WK, Tavor S, Vegesna V, Tsukasaki K, Takeuchi S, and Koeffler HP (2002). Mutations of the CHK2 gene are found in some osteosarcomas, but are rare in breast, lung, and ovarian tumors. Genes Chromosomes Cancer 33, 17-21.
111. Chen HJ, Cho CL, Liang CL, Lu K, and Lin JW (2002). Implication of telomere length as a proliferation-associated marker in schwannomas. J Surg Oncol 81, 93-100; discussion 100.
112. Bayani J, Pandita A, and Squire JA (2005). Molecular cytogenetic analysis in the study of brain tumors: findings and applications. Neurosurg Focus 19, E1.
113. Murnane JP (2010). Telomere loss as a mechanism for chromosome instability in human cancer. Cancer Res 70, 4255-4259.
114. Shugay M, Ortiz de Mendibil I, Vizmanos JL, and Novo FJ (2012). Genomic hallmarks of genes involved in chromosomal translocations in hematological cancer. PLoS Comput Biol 8, e1002797.
115. Mills KD, Ferguson DO, and Alt FW (2003). The role of DNA breaks in genomic instability and tumorigenesis. Immunol Rev 194, 77-95.
116. Nambiar M, Kari V, and Raghavan SC (2008). Chromosomal translocations in cancer. Biochim Biophys Acta 1786, 139-152.
117. Bower K, Napier CE, Cole SL, Dagg RA, Lau LM, Duncan EL, Moy EL, and Reddel RR (2012). Loss of wild-type ATRX expression in somatic cell hybrids segregates with activation of Alternative Lengthening of Telomeres. PLoS One 7, e50062.